Drug Formulary

Drugs

This is free text area. Discuss with the content team.

XXXX

Drug Formulary information is intended for use by healthcare professionals. It is not intended to be medical advice. Some of the information, including information about funding for cancer drugs, does not apply to all patients. Cancer treatment plans are unique to each patient. If you are a patient, please speak with your healthcare team to understand how this information applies to you.

Funded Evidence-informed Regimens

This is free text area. Discuss with the content team.

XXX

What's New - Drugs

This is free text area. Discuss with the content team.

Showing drugs updated within 30 days.

XXXX

Displaying Results

Filters

Name

Showing 3 of 3 results

drug

erdafitinib

NEW Sep 2026

Date:: 22 Sep 2026
Revision Summary:: Drug Monograph: new drug monograph
Patient Info Sheet EN: New drug information sheet
Patient Info Sheet FR: New information sheet (Nouvelle fiche d'information)
Cancer Type:: Genitourinary, Bladder Urothelial

Quick Link(s):

Drug Monograph , Patient Info Sheet

drug

lazertinib

NEW Sep 2026

Date:: 22 Sep 2026
Revision Summary:: Drug Monograph: New drug monograph
Patient Info Sheet FR: New information sheet (Nouvelle fiche d'information)
Cancer Type:: Lung, Non-Small Cell

Quick Link(s):

Drug Monograph

drug

quizartinib

NEW Sep 2026

Date:: 21 Sep 2026
Revision Summary:: Drug Monograph: New drug monograph
Patient Info Sheet EN: New drug information sheet
Cancer Type:: Hematologic, Leukemia - Acute Myeloid (AML)

Quick Link(s):

Drug Monograph , Patient Info Sheet

/ 1

Last Updated: September 24, 2026

The information on this website is intended for informational purposes only and is not a substitute for medical advice. Always consult your health care provider if you have questions or concerns. The use of the information on this website does not create a physician-patient relationship between Ontario Health and you.
Ontario Health is committed to ensuring accessible services and communications to individuals with disabilities. To receive any information on this website in an alternate format, please contact Ontario Health’s Communications Department at: 1-877-280-8538, TTY 1-800-855-0511, or by email at info@ontariohealth.ca.

Drug Formulary

Drugs

Displaying Results

Filters

Filters

Cancer Type

Name

abemaciclib

abiraterone

acalabrutinib

AFAtinib

aflibercept

aldesleukin

alectinib

alemtuzumab

alpelisib

amivantamab

amsacrine

anagrelide

anastrozole

apalutamide

aprepitant / fosaprepitant

arsenic trioxide

asciminib

atezolizumab

atezolizumab (subcut)

avelumab

aXitinib

azaCITIDine

azaCITIDine (tablets)

BCG

belzutifan

bendamustine

bevacizumab

bicalutamide

binimetinib

bleomycin

blinatumomab

bortezomib

bosutinib

brentuximab vedotin

brigatinib

buserelin

busulfan

cabazitaxel

cabozantinib (tablet)

calaspargase pegol

capecitabine

capivasertib

CARBOplatin

carfilzomib

carmustine

cemiplimab

ceritinib

cetuximab

chlorambucil

CISplatin

cladribine

clodronate

cobimetinib

crisantaspase recombinant

crizotinib

cyclophosphamide

cyproterone

cytarabine

daBRAFenib

dacarbazine

dacomitinib

DACTINomycin

daratumumab

daratumumab (subcut)

darbepoetin

darolutamide

daSATinib

DAUNOrubicin

decitabine / cedazuridine

degarelix

denosumab

dexamethasone

dexrazoxane